IDYA

NASDAQ · Biotechnology

Ideaya Biosciences Inc

Mid-Cap Stocks Biotech Stocks Healthcare Stocks

$36.26

+0.22 (+0.60%)

Analyst Consensus

Strong Buy

Analysts

High

Coverage

Buy 20 87%

Hold 3 13%

Sell 0 0%

Price Target

Analyst Price Target +224.6% upside

Low Target $81.99

Average Target $117.67

High Target $158.58

Current Price $36.26

Current
$36.26

Target
$117.67

$81.99 $117.67 avg $158.58

Scenario Analysis

Bear Case

$81.99

126.1%

Low target

Base Case

$117.67

+224.6%

Avg target

Bull Case

$158.58

+337.4%

High target

Risk/Reward

2.7x

Favorable

Price in Context

52-Week High

$40.58

-10.7% from high

52-Week Low

$22.09

+64.1% from low

50-Day SMA

$34.24

+5.9% vs SMA

200-Day SMA

$27.52

+31.7% vs SMA

RSI (14)

49.6

Neutral

Target vs 52W High

$117.67

+190.0% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	39	79%	$257.58	+5.4%
AMGN Amgen Inc	Hold	43	49%	$190.87	-52.7%
GILD Gilead Sciences Inc	Strong Buy	37	81%	$362.68	+179.1%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	40	83%	$438.34	-9.5%
REGN Regeneron Pharmaceuticals	Buy	38	71%	$76.80	-90.0%
RVMD Revolution Medicines Inc	Strong Buy	29	93%	$114.11	-42.1%
NTRA Natera Inc	Strong Buy	30	87%	$142.91	-46.0%
BIIB Biogen Inc	Buy	44	64%	$91.45	-55.7%